投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
暫無(wú)數(shù)據(jù)
中國(guó)人發(fā)表比例
2019年中國(guó)人文章占該期刊總數(shù)量∞% (2018年為暫無(wú)數(shù)據(jù))
自引率
7.6 %
年文章數(shù)
442
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):4229)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):1357次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):159次)
NCBI查詢(xún)
偏重的研究方向
暫無(wú)數(shù)據(jù)
期刊簡(jiǎn)介
稿件收錄要求

Endocrine Pathology?(official journal of the Endocrine Pathology Society) publishes research on clinical and basic aspects of endocrine disorders, focusing on diagnostic aspects of endocrine pathology. Coverage includes clinical case presentations and descriptions of techniques. Particular attention is paid to developments in new diagnostic applications of molecular biology and immunohistochemistry.

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.